Executives in Transition - Healthcare Services & Life Sciences Chief Executive Officer

Positioned high-profile pharmaceutical companies to outpace competitors through complex, transformative change initiatives, closing profitability gaps from –16% to +20% across Fortune 100 divisions and delivering $42M in EBITDA gains within five years.
Responsible for building a medical portfolio from the ground up, including the acquisition of 40 healthcare practices, surgical centers, and multiple billing and EMR organizations.
Oversaw the successful transition of six CEOs within 18 months, serving as interim leader during each period of change while driving the company’s first healthcare acquisitions. Established a new healthcare division by launching an MSO, developing corporate infrastructure, strengthening physician partnerships, and expanding medical and surgical operations.
Secured individual funding between $16M and $100M for each acquisition deal. Inspired confidence and followership through inclusive, transparent leadership that builds strong alliances and fosters collaboration across global teams.
Delivered 35%+ vendor cost savings and a 25% reduction in anesthesiologist fees through strategic contract renegotiations, new CRM implementation, and supplier optimization, while building and leading a high-performing 10-member team that achieved 25%+ YoY revenue growth, 100% retention, and 40% internal promotions.

Recent Posts